Skip to main content
. 2018 Oct 15;19(10):3167. doi: 10.3390/ijms19103167

Figure 5.

Figure 5

MSA protects normal cells and results in elevated cell killing of malignant cells after 48 h. (a) MSA treatment alone significantly reduces cell viability of malignant THP1 cells compared to normal PBMCs; (b) MSA does not significantly alter cell viability of PBMCs compared to THP1 cells in response to radiation; (c,d) MSA significantly protects normal PBMCs from cell death while enhancing the therapeutic activity of AraC or Dox in THP1 cells. n = 3 ± SEM, * p < 0.05, ** p < 0.01, *** p < 0.001, ns, not significant.